Colgate-Palmolive Company Logo

Colgate-Palmolive Company

CL

(4.0)
Stock Price

93,56 USD

25.03% ROA

1192.03% ROE

29.03x PER

Market Cap.

82.182.610.460,00 USD

7053.66% DER

1.95% Yield

14.21% NPM

Colgate-Palmolive Company Stock Analysis

Colgate-Palmolive Company Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Colgate-Palmolive Company Fundamental Stock Analysis
# Analysis Rating
1 ROE

ROE surpassing expectations (2018.63%) highlights strong profitability and efficient use of shareholders' equity, making it an appealing investment prospect.

2 ROA

The stock's ability to make a lot of money from its assets shows that it is very profitable, making it a good choice for people who want to invest and make a lot of money.

3 PBV

With a remarkably low PBV ratio (-6933.21x), the stock offers substantial upside potential at a bargain price.

4 DER

The stock has a low debt to equity ratio (-96933%), which means it has a small amount of debt compared to the ownership it holds

5 Revenue Growth

With continuous growth in revenue over the last five years, this company has proven to be a lucrative investment option, showcasing its strong financial performance.

6 Dividend Growth

Investors can be encouraged by the company's strong dividend growth over the past five years, highlighting its ability to generate consistent returns and provide an attractive investment opportunity.

7 Dividend

With a solid track record of dividend payments over the past five years, the company has established itself as a dependable choice for investors seeking consistent income.

8 Assets Growth

With a track record of continuous revenue growth in the last three years, this company offers a promising investment opportunity

9 Buffet Intrinsic Value

The company's stock presents an enticing opportunity as it appears undervalued (979) by Warren Buffett's formula, indicating that its intrinsic value exceeds the market price.

10 Net Profit Growth

Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors.

11 Graham Number

The Graham number of this company suggests that its stock price may be overvalued, indicating a less favorable investment opportunity.

Colgate-Palmolive Company Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Colgate-Palmolive Company Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Colgate-Palmolive Company Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Colgate-Palmolive Company Revenue
Year Revenue Growth
1985 4.523.700.000
1986 4.984.600.000 9.25%
1987 5.647.500.000 11.74%
1988 4.734.300.000 -19.29%
1989 5.038.800.000 6.04%
1990 5.691.300.000 11.46%
1991 6.060.300.000 6.09%
1992 7.007.200.000 13.51%
1993 7.141.300.000 1.88%
1994 7.587.900.000 5.89%
1995 8.358.200.000 9.22%
1996 8.749.000.000 4.47%
1997 9.056.700.000 3.4%
1998 8.971.600.000 -0.95%
1999 9.118.200.000 1.61%
2000 9.357.900.000 2.56%
2001 9.427.800.000 0.74%
2002 9.294.300.000 -1.44%
2003 9.903.400.000 6.15%
2004 10.584.200.000 6.43%
2005 11.396.900.000 7.13%
2006 12.237.700.000 6.87%
2007 13.789.700.000 11.25%
2008 15.329.900.000 10.05%
2009 15.327.000.000 -0.02%
2010 15.564.000.000 1.52%
2011 16.734.000.000 6.99%
2012 17.085.000.000 2.05%
2013 17.420.000.000 1.92%
2014 17.277.000.000 -0.83%
2015 16.034.000.000 -7.75%
2016 15.195.000.000 -5.52%
2017 15.454.000.000 1.68%
2018 15.544.000.000 0.58%
2019 15.693.000.000 0.95%
2020 16.471.000.000 4.72%
2021 17.421.000.000 5.45%
2022 17.967.000.000 3.04%
2023 19.660.000.000 8.61%
2023 19.457.000.000 -1.04%
2024 20.232.000.000 3.83%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Colgate-Palmolive Company Research and Development Expenses
Year Research and Development Expenses Growth
1985 0
1986 0 0%
1987 0 0%
1988 0 0%
1989 0 0%
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 229.200.000 100%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 259.000.000 100%
2013 267.000.000 3%
2014 277.000.000 3.61%
2015 274.000.000 -1.09%
2016 289.000.000 5.19%
2017 285.000.000 -1.4%
2018 277.000.000 -2.89%
2019 281.000.000 1.42%
2020 290.000.000 3.1%
2021 307.000.000 5.54%
2022 320.000.000 4.06%
2023 0 0%
2023 343.000.000 100%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Colgate-Palmolive Company General and Administrative Expenses
Year General and Administrative Expenses Growth
1985 1.566.200.000
1986 1.760.000.000 11.01%
1987 2.094.200.000 15.96%
1988 1.645.600.000 -27.26%
1989 1.760.300.000 6.52%
1990 2.015.600.000 12.67%
1991 2.482.400.000 18.8%
1992 2.500.200.000 0.71%
1993 2.457.100.000 -1.75%
1994 2.625.200.000 6.4%
1995 2.879.600.000 8.83%
1996 3.052.100.000 5.65%
1997 3.237.000.000 5.71%
1998 3.197.100.000 -1.25%
1999 3.254.400.000 1.76%
2000 3.299.600.000 1.37%
2001 3.261.600.000 -1.17%
2002 3.034.000.000 -7.5%
2003 3.296.300.000 7.96%
2004 2.332.400.000 -41.33%
2005 3.920.800.000 40.51%
2006 4.355.200.000 9.97%
2007 4.973.000.000 12.42%
2008 5.422.300.000 8.29%
2009 5.282.000.000 -2.66%
2010 5.414.000.000 2.44%
2011 5.758.000.000 5.97%
2012 5.930.000.000 2.9%
2013 6.223.000.000 4.71%
2014 5.982.000.000 -4.03%
2015 5.464.000.000 -9.48%
2016 5.249.000.000 -4.1%
2017 5.497.000.000 4.51%
2018 5.389.000.000 -2%
2019 3.881.000.000 -38.86%
2020 4.071.000.000 4.67%
2021 4.410.000.000 7.69%
2022 4.568.000.000 3.46%
2023 0 0%
2023 4.406.000.000 100%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Colgate-Palmolive Company EBITDA
Year EBITDA Growth
1985 296.400.000
1986 380.600.000 22.12%
1987 657.400.000 42.11%
1988 452.100.000 -45.41%
1989 434.200.000 -4.12%
1990 678.600.000 36.02%
1991 393.400.000 -72.5%
1992 1.011.800.000 61.12%
1993 1.235.200.000 18.09%
1994 1.367.300.000 9.66%
1995 1.951.800.000 29.95%
1996 1.655.900.000 -17.87%
1997 1.702.400.000 2.73%
1998 1.816.000.000 6.26%
1999 2.053.600.000 11.57%
2000 2.008.300.000 -2.26%
2001 2.184.100.000 8.05%
2002 2.278.800.000 4.16%
2003 2.468.600.000 7.69%
2004 2.554.600.000 3.37%
2005 2.613.500.000 2.25%
2006 2.757.800.000 5.23%
2007 3.082.300.000 10.53%
2008 3.368.300.000 8.49%
2009 3.966.000.000 15.07%
2010 4.166.000.000 4.8%
2011 4.262.000.000 2.25%
2012 4.314.000.000 1.21%
2013 3.995.000.000 -7.98%
2014 3.999.000.000 0.1%
2015 5.406.000.000 26.03%
2016 4.355.000.000 -24.13%
2017 4.064.000.000 -7.16%
2018 4.205.000.000 3.35%
2019 4.073.000.000 -3.24%
2020 4.424.000.000 7.93%
2021 5.030.000.000 12.05%
2022 4.880.000.000 -3.07%
2023 4.116.000.000 -18.56%
2023 4.698.000.000 12.39%
2024 5.260.000.000 10.68%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Colgate-Palmolive Company Gross Profit
Year Gross Profit Growth
1985 1.915.200.000
1986 2.181.600.000 12.21%
1987 2.579.500.000 15.43%
1988 2.091.100.000 -23.36%
1989 2.292.700.000 8.79%
1990 2.696.500.000 14.97%
1991 2.910.200.000 7.34%
1992 3.491.300.000 16.64%
1993 3.621.000.000 3.58%
1994 3.909.700.000 7.38%
1995 4.305.400.000 9.19%
1996 4.614.200.000 6.69%
1997 4.915.100.000 6.12%
1998 5.011.600.000 1.93%
1999 5.234.400.000 4.26%
2000 5.092.400.000 -2.79%
2001 5.190.900.000 1.9%
2002 5.070.100.000 -2.38%
2003 5.447.300.000 6.92%
2004 5.837.000.000 6.68%
2005 6.205.000.000 5.93%
2006 6.701.600.000 7.41%
2007 7.747.400.000 13.5%
2008 8.626.400.000 10.19%
2009 9.008.000.000 4.24%
2010 9.204.000.000 2.13%
2011 9.590.000.000 4.03%
2012 9.932.000.000 3.44%
2013 10.201.000.000 2.64%
2014 10.109.000.000 -0.91%
2015 9.399.000.000 -7.55%
2016 9.123.000.000 -3.03%
2017 9.280.000.000 1.69%
2018 9.231.000.000 -0.53%
2019 9.325.000.000 1.01%
2020 10.017.000.000 6.91%
2021 10.375.000.000 3.45%
2022 10.248.000.000 -1.24%
2023 11.508.000.000 10.95%
2023 11.251.000.000 -2.28%
2024 12.276.000.000 8.35%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Colgate-Palmolive Company Net Profit
Year Net Profit Growth
1985 171.900.000
1986 177.500.000 3.15%
1987 54.000.000 -228.7%
1988 192.800.000 71.99%
1989 280.000.000 31.14%
1990 321.000.000 12.77%
1991 124.900.000 -157.01%
1992 477.000.000 73.82%
1993 189.900.000 -151.18%
1994 580.200.000 67.27%
1995 172.000.000 -237.33%
1996 635.000.000 72.91%
1997 740.400.000 14.24%
1998 848.600.000 12.75%
1999 937.300.000 9.46%
2000 1.063.800.000 11.89%
2001 1.146.600.000 7.22%
2002 1.288.300.000 11%
2003 1.421.300.000 9.36%
2004 1.327.100.000 -7.1%
2005 1.351.400.000 1.8%
2006 1.353.400.000 0.15%
2007 1.737.400.000 22.1%
2008 1.957.200.000 11.23%
2009 2.291.000.000 14.57%
2010 2.203.000.000 -3.99%
2011 2.431.000.000 9.38%
2012 2.472.000.000 1.66%
2013 2.241.000.000 -10.31%
2014 2.180.000.000 -2.8%
2015 1.384.000.000 -57.51%
2016 2.441.000.000 43.3%
2017 2.024.000.000 -20.6%
2018 2.400.000.000 15.67%
2019 2.367.000.000 -1.39%
2020 2.695.000.000 12.17%
2021 2.166.000.000 -24.42%
2022 1.785.000.000 -21.34%
2023 2.832.000.000 36.97%
2023 2.300.000.000 -23.13%
2024 2.924.000.000 21.34%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Colgate-Palmolive Company Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1985 0
1986 0 0%
1987 0 0%
1988 0 0%
1989 0 0%
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 1 0%
1997 1 0%
1998 1 0%
1999 1 0%
2000 1 0%
2001 1 100%
2002 1 0%
2003 1 0%
2004 1 0%
2005 1 0%
2006 1 0%
2007 2 0%
2008 2 0%
2009 2 50%
2010 2 0%
2011 2 0%
2012 3 0%
2013 2 0%
2014 2 0%
2015 2 -100%
2016 3 50%
2017 2 0%
2018 3 0%
2019 3 0%
2020 3 33.33%
2021 3 -50%
2022 2 0%
2023 3 33.33%
2023 3 -50%
2024 4 33.33%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Colgate-Palmolive Company Free Cashflow
Year Free Cashflow Growth
1989 142.600.000
1990 153.800.000 7.28%
1991 225.000.000 31.64%
1992 224.200.000 -0.36%
1993 346.100.000 35.22%
1994 428.600.000 19.25%
1995 378.400.000 -13.27%
1996 458.400.000 17.45%
1997 619.300.000 25.98%
1998 766.600.000 19.21%
1999 875.800.000 12.47%
2000 1.169.600.000 25.12%
2001 1.259.400.000 7.13%
2002 1.267.500.000 0.64%
2003 1.465.600.000 13.52%
2004 1.406.200.000 -4.22%
2005 1.395.200.000 -0.79%
2006 1.345.100.000 -3.72%
2007 1.620.600.000 17%
2008 1.554.800.000 -4.23%
2009 2.702.000.000 42.46%
2010 2.661.000.000 -1.54%
2011 2.359.000.000 -12.8%
2012 2.631.000.000 10.34%
2013 2.534.000.000 -3.83%
2014 2.541.000.000 0.28%
2015 2.258.000.000 -12.53%
2016 2.548.000.000 11.38%
2017 2.501.000.000 -1.88%
2018 2.620.000.000 4.54%
2019 2.798.000.000 6.36%
2020 3.309.000.000 15.44%
2021 2.758.000.000 -19.98%
2022 1.860.000.000 -48.28%
2023 991.000.000 -87.69%
2023 3.040.000.000 67.4%
2024 873.000.000 -248.22%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Colgate-Palmolive Company Operating Cashflow
Year Operating Cashflow Growth
1989 352.600.000
1990 450.600.000 21.75%
1991 485.700.000 7.23%
1992 542.700.000 10.5%
1993 710.400.000 23.61%
1994 829.400.000 14.35%
1995 810.200.000 -2.37%
1996 917.400.000 11.69%
1997 1.097.800.000 16.43%
1998 1.178.800.000 6.87%
1999 1.292.700.000 8.81%
2000 1.536.200.000 15.85%
2001 1.599.600.000 3.96%
2002 1.611.200.000 0.72%
2003 1.767.700.000 8.85%
2004 1.754.300.000 -0.76%
2005 1.784.400.000 1.69%
2006 1.821.500.000 2.04%
2007 2.203.700.000 17.34%
2008 2.238.300.000 1.55%
2009 3.277.000.000 31.7%
2010 3.211.000.000 -2.06%
2011 2.896.000.000 -10.88%
2012 3.196.000.000 9.39%
2013 3.204.000.000 0.25%
2014 3.298.000.000 2.85%
2015 2.949.000.000 -11.83%
2016 3.141.000.000 6.11%
2017 3.054.000.000 -2.85%
2018 3.056.000.000 0.07%
2019 3.133.000.000 2.46%
2020 3.719.000.000 15.76%
2021 3.325.000.000 -11.85%
2022 2.556.000.000 -30.09%
2023 1.152.000.000 -121.88%
2023 3.745.000.000 69.24%
2024 990.000.000 -278.28%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Colgate-Palmolive Company Capital Expenditure
Year Capital Expenditure Growth
1989 210.000.000
1990 296.800.000 29.25%
1991 260.700.000 -13.85%
1992 318.500.000 18.15%
1993 364.300.000 12.57%
1994 400.800.000 9.11%
1995 431.800.000 7.18%
1996 459.000.000 5.93%
1997 478.500.000 4.08%
1998 412.200.000 -16.08%
1999 416.900.000 1.13%
2000 366.600.000 -13.72%
2001 340.200.000 -7.76%
2002 343.700.000 1.02%
2003 302.100.000 -13.77%
2004 348.100.000 13.21%
2005 389.200.000 10.56%
2006 476.400.000 18.3%
2007 583.100.000 18.3%
2008 683.500.000 14.69%
2009 575.000.000 -18.87%
2010 550.000.000 -4.55%
2011 537.000.000 -2.42%
2012 565.000.000 4.96%
2013 670.000.000 15.67%
2014 757.000.000 11.49%
2015 691.000.000 -9.55%
2016 593.000.000 -16.53%
2017 553.000.000 -7.23%
2018 436.000.000 -26.83%
2019 335.000.000 -30.15%
2020 410.000.000 18.29%
2021 567.000.000 27.69%
2022 696.000.000 18.53%
2023 161.000.000 -332.3%
2023 705.000.000 77.16%
2024 117.000.000 -502.56%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Colgate-Palmolive Company Equity
Year Equity Growth
1985 894.500.000
1986 967.400.000 7.54%
1987 928.600.000 -4.18%
1988 1.138.100.000 18.41%
1989 1.123.200.000 -1.33%
1990 1.363.600.000 17.63%
1991 1.866.300.000 26.94%
1992 2.619.800.000 28.76%
1993 1.875.000.000 -39.72%
1994 1.822.900.000 -2.86%
1995 1.679.800.000 -8.52%
1996 2.034.100.000 17.42%
1997 2.178.600.000 6.63%
1998 2.085.600.000 -4.46%
1999 1.833.700.000 -13.74%
2000 1.468.100.000 -24.9%
2001 846.400.000 -73.45%
2002 350.300.000 -141.62%
2003 887.100.000 60.51%
2004 1.506.400.000 41.11%
2005 1.350.100.000 -11.58%
2006 1.410.900.000 4.31%
2007 2.396.100.000 41.12%
2008 1.922.100.000 -24.66%
2009 3.257.000.000 40.99%
2010 2.817.000.000 -15.62%
2011 2.541.000.000 -10.86%
2012 2.390.000.000 -6.32%
2013 2.536.000.000 5.76%
2014 1.385.000.000 -83.1%
2015 -44.000.000 3247.73%
2016 17.000.000 358.82%
2017 243.000.000 93%
2018 197.000.000 -23.35%
2019 558.000.000 64.7%
2020 1.101.000.000 49.32%
2021 971.000.000 -13.39%
2022 806.000.000 -20.47%
2023 957.000.000 15.78%
2023 406.000.000 -135.71%
2024 482.000.000 15.77%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Colgate-Palmolive Company Assets
Year Assets Growth
1985 2.814.000.000
1986 2.845.900.000 1.12%
1987 3.227.700.000 11.83%
1988 3.217.600.000 -0.31%
1989 3.536.500.000 9.02%
1990 4.157.900.000 14.95%
1991 4.510.600.000 7.82%
1992 5.434.100.000 16.99%
1993 5.761.200.000 5.68%
1994 6.142.400.000 6.21%
1995 7.642.300.000 19.63%
1996 7.901.500.000 3.28%
1997 7.538.700.000 -4.81%
1998 7.685.200.000 1.91%
1999 7.423.100.000 -3.53%
2000 7.252.300.000 -2.36%
2001 6.984.800.000 -3.83%
2002 7.087.200.000 1.44%
2003 7.478.800.000 5.24%
2004 8.672.900.000 13.77%
2005 8.507.100.000 -1.95%
2006 9.138.000.000 6.9%
2007 10.112.000.000 9.63%
2008 9.979.300.000 -1.33%
2009 11.134.000.000 10.37%
2010 11.172.000.000 0.34%
2011 12.724.000.000 12.2%
2012 13.394.000.000 5%
2013 13.876.000.000 3.47%
2014 13.459.000.000 -3.1%
2015 11.958.000.000 -12.55%
2016 12.123.000.000 1.36%
2017 12.676.000.000 4.36%
2018 12.161.000.000 -4.23%
2019 15.034.000.000 19.11%
2020 15.920.000.000 5.57%
2021 15.040.000.000 -5.85%
2022 15.731.000.000 4.39%
2023 16.393.000.000 4.04%
2023 16.043.000.000 -2.18%
2024 16.480.000.000 2.65%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Colgate-Palmolive Company Liabilities
Year Liabilities Growth
1985 1.919.500.000
1986 1.878.500.000 -2.18%
1987 2.299.100.000 18.29%
1988 2.079.500.000 -10.56%
1989 2.413.300.000 13.83%
1990 2.794.300.000 13.63%
1991 2.644.300.000 -5.67%
1992 2.814.300.000 6.04%
1993 3.886.200.000 27.58%
1994 4.319.500.000 10.03%
1995 5.962.500.000 27.56%
1996 5.867.400.000 -1.62%
1997 5.360.100.000 -9.46%
1998 5.599.600.000 4.28%
1999 5.589.400.000 -0.18%
2000 5.784.200.000 3.37%
2001 6.138.400.000 5.77%
2002 6.736.900.000 8.88%
2003 6.591.700.000 -2.2%
2004 7.166.500.000 8.02%
2005 7.157.000.000 -0.13%
2006 7.727.100.000 7.38%
2007 7.715.900.000 -0.15%
2008 8.057.200.000 4.24%
2009 7.877.000.000 -2.29%
2010 8.355.000.000 5.72%
2011 10.183.000.000 17.95%
2012 11.004.000.000 7.46%
2013 11.340.000.000 2.96%
2014 12.074.000.000 6.08%
2015 12.002.000.000 -0.6%
2016 12.106.000.000 0.86%
2017 12.433.000.000 2.63%
2018 11.964.000.000 -3.92%
2019 14.476.000.000 17.35%
2020 14.819.000.000 2.31%
2021 14.069.000.000 -5.33%
2022 14.925.000.000 5.74%
2023 15.436.000.000 3.31%
2023 15.637.000.000 1.29%
2024 15.998.000.000 2.26%

Colgate-Palmolive Company Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
24.38
Net Income per Share
3.46
Price to Earning Ratio
29.03x
Price To Sales Ratio
4.11x
POCF Ratio
20.82
PFCF Ratio
24.47
Price to Book Ratio
670.29
EV to Sales
4.49
EV Over EBITDA
18.17
EV to Operating CashFlow
22.67
EV to FreeCashFlow
26.73
Earnings Yield
0.03
FreeCashFlow Yield
0.04
Market Cap
82,18 Bil.
Enterprise Value
89,75 Bil.
Graham Number
3.42
Graham NetNet
-15.05

Income Statement Metrics

Net Income per Share
3.46
Income Quality
1.38
ROE
11.92
Return On Assets
0.17
Return On Capital Employed
0.4
Net Income per EBT
0.72
EBT Per Ebit
0.87
Ebit per Revenue
0.22
Effective Tax Rate
0.23

Margins

Sales, General, & Administrative to Revenue
0.18
Research & Developement to Revenue
0.02
Stock Based Compensation to Revenue
0.01
Gross Profit Margin
0.6
Operating Profit Margin
0.22
Pretax Profit Margin
0.2
Net Profit Margin
0.14

Dividends

Dividend Yield
0.02
Dividend Yield %
1.95
Payout Ratio
0.56
Dividend Per Share
1.96

Operating Metrics

Operating Cashflow per Share
4.83
Free CashFlow per Share
4.1
Capex to Operating CashFlow
0.15
Capex to Revenue
0.03
Capex to Depreciation
1
Return on Invested Capital
0.39
Return on Tangible Assets
0.25
Days Sales Outstanding
33.33
Days Payables Outstanding
70.48
Days of Inventory on Hand
87.01
Receivables Turnover
10.95
Payables Turnover
5.18
Inventory Turnover
4.2
Capex per Share
0.73

Balance Sheet

Cash per Share
1,63
Book Value per Share
0,59
Tangible Book Value per Share
-5.68
Shareholders Equity per Share
0.15
Interest Debt per Share
10.87
Debt to Equity
70.54
Debt to Assets
0.53
Net Debt to EBITDA
1.53
Current Ratio
1.06
Tangible Asset Value
-4,65 Bil.
Net Current Asset Value
-10,35 Bil.
Invested Capital
9822000000
Working Capital
0,30 Bil.
Intangibles to Total Assets
0.31
Average Receivables
1,82 Bil.
Average Payables
1,60 Bil.
Average Inventory
1918000000
Debt to Market Cap
0.11

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Colgate-Palmolive Company Dividends
Year Dividends Growth
1973 0
1974 1 0%
1975 1 0%
1976 1 0%
1977 1 0%
1978 1 100%
1979 1 0%
1980 1 0%
1981 1 0%
1982 1 0%
1983 1 0%
1984 1 0%
1985 1 0%
1986 1 0%
1987 1 0%
1988 1 0%
1989 2 0%
1990 2 0%
1991 2 0%
1992 1 0%
1993 1 0%
1994 2 0%
1995 2 0%
1996 2 0%
1997 2 0%
1998 1 0%
1999 1 0%
2000 1 0%
2001 1 0%
2002 1 0%
2003 1 0%
2004 1 0%
2005 1 100%
2006 1 0%
2007 1 0%
2008 2 0%
2009 2 0%
2010 2 50%
2011 2 0%
2012 2 0%
2013 2 -100%
2014 1 0%
2015 2 0%
2016 2 0%
2017 2 0%
2018 2 0%
2019 2 0%
2020 2 0%
2021 2 0%
2022 2 0%
2023 2 0%
2024 2 0%

Colgate-Palmolive Company Profile

About Colgate-Palmolive Company

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

CEO
Mr. Noel R. Wallace
Employee
34.000
Address
300 Park Avenue
New York, 10022-7499

Colgate-Palmolive Company Executives & BODs

Colgate-Palmolive Company Executives & BODs
# Name Age
1 Mr. Panagiotis Tsourapas
Group President of Europe & Developing Markets
70
2 Valerie Haliburton
Senior Vice President of Global Ethics & Compliance
70
3 Mr. John Faucher
Chief Investor Relations Officer and Executive Vice President of M&A
70
4 Mr. Noel R. Wallace
Chairman, Chief Executive Officer & President
70
5 Ms. Jennifer M. Daniels
Chief Legal Officer & Secretary
70
6 Ms. Sally Massey
Chief Human Resources Officer
70
7 Mr. David Foster
Chief Information Officer
70
8 Ms. Prabha Parameswaran
Group President of Growth & Strategy
70
9 Mr. Stanley J. Sutula III
Chief Financial Officer
70
10 Mr. Stephan Habif
Chief Technology Officer
70

Colgate-Palmolive Company Competitors